INSTITUTO DE INVESTIGACIÓN BIOMÉDICA DE SALAMANCA
Instituto
Wrocław Medical University
Breslavia, PoloniaPublicaciones en colaboración con investigadores/as de Wrocław Medical University (9)
2024
-
Decoding the historical tale: COVID-19 impact on haematological malignancy patients—EPICOVIDEHA insights from 2020 to 2022
eClinicalMedicine, Vol. 71
-
Graft-versus-Host Disease Prophylaxis with Post- Transplantation Cyclophosphamide in Chronic Myeloid Leukemia Patients Undergoing Allogeneic Hematopoietic Cell Transplantation from an Unrelated or Mismatched Related Donor: A Comparative Study from the Chronic Malignancies Working Party of the EBMT (CMWP-EBMT)
Transplantation and Cellular Therapy, Vol. 30, Núm. 1, pp. 93.e1-93.e12
2023
2019
-
Exome sequencing identifies germline variants in DIS3 in familial multiple myeloma
Leukemia
-
Safety and activity of ibrutinib in combination with nivolumab in patients with relapsed non-Hodgkin lymphoma or chronic lymphocytic leukaemia: a phase 1/2a study
The Lancet Haematology, Vol. 6, Núm. 2, pp. e67-e78
2016
-
Central nervous system involvement by multiple myeloma: A multi-institutional retrospective study of 172 patients in daily clinical practice
American Journal of Hematology, Vol. 91, Núm. 6, pp. 575-580
-
Cutaneous involvement in multiple myeloma: a multi-institutional retrospective study of 53 patients
Leukemia and Lymphoma, Vol. 57, Núm. 9, pp. 2071-2076
2014
-
Tolerability to romidepsin in patients with relapsed/refractory T-cell lymphoma
Biomarker Research, Vol. 2, Núm. 1
2009
-
Cidofovir for BK virus-associated hemorrhagic cystitis: A retrospective study
Clinical Infectious Diseases, Vol. 49, Núm. 2, pp. 233-240